Tuesday, November 18, 2008
HOW TO DIAGNOSE PROSTATE CANCER
2.DIGITAL RECTAL EXAMINATION (DRE)-- This is an outpatient procedure which is done with a finger inserted into the rectum to assess the prostate gland.
3.BIOPSY --- If the PSA and DRE are abnormal, then the patient is advised to undergo a biopsy.This procedure can be done as an outpatient with the help of a transrectal ultrasound probe.It is usually painless, and takes about 10 minutes.Sometimes, there may be a liitle bleeding after the procedure which usually subsides in a few hours. Multiple bits of the prostate tissue from different quadrants are removed from the prostate gland and sent for histopathology examination.This test will confirm whether a malignancy is present or not. The pathologist will give a report on a.whether a malignancy is present,
b.if present, then which quadrants are positive,
c. what type of maligancy is present(adenocarcinoma is the commonest)
d.Gleason's score.The gleasons score usually determines the aggressiveness of the cancer, a lower score meaning less aggressive and a higher score meaning more aggressive tumor.
The treatment decisions are taken after all this information is ready.
4.DIAGNOSTIC IMAGING: Once a cancer is confirmed, further tests like transrectal ultrasound,CT /MRI /PET CT scans , NUCLEAR BONE SCANS may be ordered to know the extent of the disease and hence stage it.
Tuesday, November 4, 2008
What is prostate gland?
The three most common forms of prostate disease are
Diagram showing the position of the prostate gland
SYMPTOMS OF PROSTATE CANCER
Symptoms of prostate cancer can vary from patient to patient.Symptoms can mimic those of benign prostatic hypertrophy or prostatism.
Sunday, November 2, 2008
Prostate cancer is a disease in which cancer develops in the prostate, a gland in the male reproductive system. It occurs when cells of the prostate mutate and begin to multiply out of control. These cells may spread (metastasize) from the prostate to other parts of the body, especially the bones and lymph nodes. Prostate cancer may cause pain, difficulty in urinating, erectile dysfunction and other symptoms.This cancer can occur only in men, as the prostate gland is found only in the male reproductive tract. It is one of the most common types of cancer in men.
PROSTATE CANCER incidence
The term 'prevalence' of Prostate Cancer usually refers to the estimated population of people who are managing Prostate Cancer at any given time. The term 'incidence' of Prostate Cancer refers to the annual diagnosis rate, or the number of new cases of Prostate Cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence.
Prostate cancer incidence statistics for men in various countries:
112.3 men per 100,000 population with prostate cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
80.2 men per 100,000 population with prostate cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
63 men per 100,000 population with prostate cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
42.2 men per 100,000 population with prostate cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
39.6 men per 100,000 population with prostate cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
32 men per 100,000 population with prostate cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
29.9 men per 100,000 population with prostate cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
22.2 men per 100,000 population with prostate cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
13.9 men per 100,000 population with prostate cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
9.0 men per 100,000 population with prostate cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
8.6 men per 100,000 population with prostate cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
7.4 men per 100,000 population with prostate cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)